Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer’s disease

Neurobiology of Disease

Volumn 8, Issue 1, 2001, Pages 136-146

  Shepherd, Claire E ^a   Thiel, Emma ^a   McCann, Heather ^a   Halliday, Glenda M ^a  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFILAMENT PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROFILAMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL; TEMPORAL LOBE;

EID: 0035110036     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2000.0361     Document Type: Article

References (33)

1. Neuropathological staging of Alzheimer-related changes
2. Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimerrs disease
3. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase
4. Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease
5. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease
6. Topography of brain atrophy during normal aging and Alzheimer's disease
7. Immunoreactivity patterns in neurofibrillary tangles of the inferior temporal cortex in Alzheimer's disease
8. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease
9. Sabeluzole stabilizes the neuronal cytoskeleton
10. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
11. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease
12. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis
13. Effects of antiinflammatory medications on neuropathological findings in Alzheimer's Disease
14. Specific temporoparietal gyral atrophy reflects the pattern of language dissolution in Alzheimer's disease
15. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex
16. Cytoskeletal pathology of parkinsonism and aging brain
17. Neurofilament functions in health and disease
18. Neurofilaments in health and disease
19. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis
20. An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease
21. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardisation of the neuropathologic assessment of Alzheimer's disease
22. Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation by tau protein kinase II
23. The Clinical Dementia Rating (CDR): Current version and scoring rules
24. A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease
25. Neurofilament phosphorylation
26. Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by post-synaptic calcium-dependent mechanisms
27. Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeletal function
28. Recent developments in the drug treatment of Alzheimer's disease
29. Aggregation of neurofilament and alpha synuclein proteins in Lewy bodies
30. Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease
31. The cause of neuronal degeneration in Alzheimer's disease
32. Alterations in neurofilament protein immunoreactivity, in human hippocampal neurons related to normal aging and Alzheimer's disease
33. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K